MentionFox
Home › funding signals › Yemaachi Biotechnology
Accelerator · announced

Yemaachi Biotechnology (YC S21) — Diversifying precision cancer diagnostics and treatments

Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones.

Yemaachi Biotechnology is a Y Combinator company in the Summer 2021 batch. Its directory entry describes it as: Diversifying precision cancer diagnostics and treatments. The founders listed are Yaw Bediako (Founder), Yaw Attua-Afari (Founder), David Hutchful (Founder) (Y Combinator directory entry, August 1, 2021).

6 more companies from YC Summer 2021 ↓

Run the free check on Yemaachi Biotechnology →

Sell to companies like Yemaachi Biotechnology? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Yemaachi Biotechnology

New accelerator entry · 2021-08-01 · the record

Summer 2021
batch
16
people
Early
stage
Ghana
region
Open the record →

What the record says

BatchSummer 2021
Announced2021-08-01
StageEarly
StatusActive
Team size16
IndustryHealthcare
Sub-industryHealthcare -> Diagnostics
SectorsBiotech, Diagnostics, Therapeutics
RegionsGhana, Africa
BasedAccra, Greater Accra Region, Ghana
HiringNo
Sitehttps://yemaachi.com/

Pitching, partnering or investing alongside them? See who really runs and owns Yemaachi Biotechnology.

Free to see. No signup.

Keep reading

More on Yemaachi Biotechnology and the records around it.

Also in YC Summer 2021

Same batch, Healthcare first.

What do you want to do with Yemaachi Biotechnology?

Get the full cited report on Yemaachi Biotechnology

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Yemaachi Biotechnology: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.

Want the whole picture on Yemaachi Biotechnology?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Yemaachi Biotechnology: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Yemaachi Biotechnology covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Yemaachi Biotechnology: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Yemaachi Biotechnology. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups Medical device and diagnostics startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Yemaachi Biotechnology: Accepted into Y Combinator Summer 2021
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-yemaachi-biotechnology
Last updated 2026-10-20
Primary record: Y Combinator directory entry
Yemaachi Biotechnology (YC S21) — Diversifying precision cancer diagnostics and treatments. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-yemaachi-biotechnology